Review the Association of Ala513Pro and Gly972Arg IRS-1 Gene Polymorphism with Gestational Diabetes Mellitus in South of Iran
محورهای موضوعی : Report of Health Care
Heydar Aghababa
1
(
Department of biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran
)
Sana Edalat Panah
2
(
Department of biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran
)
Bahareh Jokar
3
(
Department of biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran
)
کلید واژه: Iran, Gestational Diabetes, Polymorphism,
چکیده مقاله :
Introduction: Gestational diabetes mellitus is a multi-factor disease. Several genes are shown to be associated with diabetes mellitus. Among them, IRS-1 gene is located on chromosome No.2 which is an endogen substrate for insulin receptor. IRS-1 gene has an important role in insulin pathway signaling. Aim of this study was to review the association of Ala513Pro and Gly972Arg IRS-1 gene polymorphism with gestational diabetes mellitus in south of Iran. Methods: 200 subjects with gestational diabetes mellitus and 200 healthy subjects as control group were enrolled in the study. DNA was extracted from their blood and polymorphism of G, C and T allele were studied. It was aimed to investigate whether genotype is associated with clinical and biochemical variables such as family history, fasting blood sugar, blood lipid and body mass index. Independent sample t- test, chi- square test, logistic regression and Hardy- Weinberg equilibrium tests were used to analyze data (p≤0.05). Results: The finding from the Polymorphism Gly972Arg study show that individuals with CC, CT genotypes were associated with an increased risk of the disease (%95CI: 0.02-0.44, OR=0.1, P<0.001), (%95CI:2-58.43, OR=9.2, P<0.01). There was no allele and genotypic variation in Polymorphism Ala513Pro Polymorphism. Conclusion: Based on the obtained results, Ala 513Pro polymorphism of the IRS-1 gene was not correlated, but Gly 972 Arg polymorphism related with gestational diabetes mellitus in population of south Iran.
1. Ansari Sh. Williams obstetrics. 25 ed. Golban Medical Publication. 2018.
2. Zare Z, Meshkibaf MH, Hamaiatkhah V, Ranjbaran R, Takhshid MA. Positive correlation of resistinwith blood lipids in gestational diabetes. J Fums. 2013; 4: 330- 334.
3. Niyafar M, Salem A, Asgharzadeh AA. Risks factors for gestational diabetes and prevalence of impaired glucose tolerance six weeks after delivery. Tabriz Med Sci Univ J 2017; 39 (5): 73- 80.
4. Clause JO, Hensen T, Bjorbaek C, Echwald SM, Urhamer SA, Rasmussen S, et al. Insulin resistance interaction between obesity and a common variant ofinsulin receptor substrate-1. Lancet. 1995; 346: 397- 402.
5. Groop L, Lyssenko V. Genes and type 2 diabetes mellitus. Curr Diab Rep. 2008; 8 (3): 192- 197.
6. Baroudi Oiederni T, Sanchez-Corona J, Fadiel A, Jhonson-Scalise T, Beeghly-Fadiel A, Flores Martinez S, et al. Polymorphism study of the insulin receptor substrate IRS- 1 and IRS- 2 genes associated with type 2 diabetes in ethnic groups djirba island . Clin Med Revies. 2010; 2: 185- 190.
7. Buchanan TR, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes?. Diabetes Care. 2007; 302: 105- 111.
8. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Amino- acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 1996; 342 (8875): 828- 832.
9. Saravani R, Noorzehi N, Galavi HR, Ranjbar N, Lotfian sargazi M. Association of perilipin and IRS-1 genes polymorphism with lipid profiles, central obesity and type 2 diabetes in a sample of Iranian population. Iran Red Cres Med. 2017; 19 (6): 55- 63.
10. Cornelis MC, Hu FB. Gene-environment
interactions in the development of type 2 diabetes: recent progress and continuing challenges. Annu Rev Nutr. 2012; 32: 245- 259.
11. Sheikhha MH, Afkhami- Ardakani MR, Mirjalili MR, Dehghani MR, et al. Investigating the frequency of mspi polymorphism of APOA1 gene type 2 diabetic patients and comparing it with this frequency in non-diabetics. Genetics. 2013; 3: 3079- 3083.
12. Ghorbani M. A review of type 2 diabetes and obesity. Mol Cell Biot. 2015; 5 (18): 9- 14.
13. Hart LM, Stolk RP, Dekker JM, Nijpels G, Grobbee DE, Heine RJ. Prevalence of variants in candidate gene for type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999; 84: 1002- 1006.
14. Arikoglu H, Askoy hepdogru M, Erkoc kaya D, Asik A, Hilmi ipekci S, Iscioglu F, et al. Irs-1 gene polymorphism Gly972 Arg and Ala513Pro are not associated with insulin resistance and type 2 diabetes risk in non- obese Turkish population. Meta Gene. 2014; 2: 579- 585.
15. Bodhini D, Radha V, Mohan V. Association study of IRS-1 gene polymorphism with type 2 diabetes in south Indians. Diabetes Technol Ther. 2011; 7: 767- 772.
